Materials domain / 05

Biomaterials & Anticancer Platforms

Biointerfaces, drug-delivery materials, anticancer nanoplatforms, toxicity-aware design, and therapeutic response.

01 / Biomaterials

Core scientific questions

How composition, bonding, defects, interfaces, morphology, and environment govern biomaterials behavior.

02 / Biomaterials

Experimental evidence

How synthesis, processing, calibrated characterization, controls, and uncertainty support defensible conclusions in biomaterials.

  • Drug delivery
  • Biointerfaces
  • Cytotoxicity
  • Targeted systems
03 / Biomaterials

Computational interpretation

How electronic-structure calculations, atomistic simulation, continuum models, or data-driven methods can test mechanisms without replacing validation.

04 / Biomaterials

Engineering translation

How performance, reliability, manufacturability, safety, sustainability, and scale-up constrain useful material solutions.

  • Electronic: Band structure, bonding, charge, and reactivity
  • Atomic: Defects, diffusion, ordering, and local chemistry
  • Nano: Interfaces, confinement, surface area, and morphology
  • Micro: Grains, phases, pores, cracks, and reinforcement
  • Macro: Strength, transport, reliability, and degradation
  • System: Manufacturing, devices, sustainability, and deployment